Gsk (GSK) EPS (Basic) (2009 - 2026)
Gsk (GSK) posted quarterly EPS (Basic) of $0.14 for Q2 2026, down 69.49% year-over-year from $0.47 in Q2 2025, and down 75.08% quarter-over-quarter from $0.58 in Q1 2026.
Gsk (GSK) EPS (Basic) (2009 - 2026) Analysis & Trends
Gsk's EPS (Basic) history runs 18 years deep, the most recent figure standing at $0.14 for Q2 2026.
- In Q2 2026, EPS (Basic) fell 69.49% year-over-year to $0.14; the TTM figure through Jun 2026 stood at $2.4 (up 45.09% YoY), while the FY2025 annual figure was $1.86, up 130.44% from the prior year.
- EPS (Basic) for Q2 2026 stood at $0.14, down from $0.58 in the prior quarter.
- The five-year high for EPS (Basic) was $4.36 in Q4 2022, with the low at -$0.02 in Q3 2024.
- The 5-year median for EPS (Basic) is $0.5 (2023), against an average of $0.86.
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) plunged 104.04% in 2024, then surged 3697.34% in 2025.
- Gsk's EPS (Basic) stood at $4.36 in 2022, then sank by 78.11% to $0.95 in 2023, then dropped by 26.76% to $0.7 in 2024, then jumped by 44.16% to $1.01 in 2025, then sank by 85.69% to $0.14 in 2026.
- Business Quant data shows GSK's EPS (Basic) at $0.14 in Q2 2026, $0.58 in Q1 2026, and $1.01 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 2.30 |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 1.71 |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 1.62 |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 4.40 |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -0.04 |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 0.29 |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.14 |
| Mar 31, 2026 | 0.58 |
| Dec 31, 2025 | 1.01 |
| Sep 30, 2025 | 0.67 |
| Jun 30, 2025 | 0.47 |
| Mar 31, 2025 | 0.50 |
| Dec 31, 2024 | 0.70 |
| Sep 30, 2024 | -0.02 |
| Jun 30, 2024 | 0.36 |
| Mar 31, 2024 | 0.33 |
| Dec 31, 2023 | 0.95 |
| Sep 30, 2023 | 0.46 |
| Jun 30, 2023 | 0.50 |
| Mar 31, 2023 | 0.45 |
| Dec 31, 2022 | 4.36 |
| Sep 30, 2022 | 3.19 |
| Jun 30, 2022 | 0.26 |
| Mar 31, 2022 | 0.60 |
| Dec 31, 2021 | 0.83 |
| Sep 30, 2021 | 0.40 |